140 related articles for article (PubMed ID: 1024896)
1. [Therapeutic procedures in chronic hepatitis and liver cirrhosis].
Davcev P; Vanovski B; Bidikov V
God Zb Med Fak Skopje; 1976; 22():397-405. PubMed ID: 1024896
[No Abstract] [Full Text] [Related]
2. [Long-term treatment of chronic aggressive hepatitis and liver cirrhosis using immunosuppressive agents].
Bannaski H
Med Welt; 1974 Sep; 25(39):1551-5. PubMed ID: 4427553
[No Abstract] [Full Text] [Related]
3. Controlling chronic liver disease. Part 1.
Rodman MJ
RN; 1976 Jan; 39(1):79-80, 84-5. PubMed ID: 1043138
[No Abstract] [Full Text] [Related]
4. [Immunoprevention and immunosuppression of chronic inflammatory liver diseases].
Scheiffarth F
Med Welt; 1974 Oct; 25(40):1589-92. PubMed ID: 4444495
[No Abstract] [Full Text] [Related]
5. [Active chronic hepatitis. Criteria adopted and results in recent specialist studies].
Carotti A
Minerva Med; 1980 Nov; 71(47):3429-34. PubMed ID: 7454095
[No Abstract] [Full Text] [Related]
6. [Clinico-morphological dynamics of chronic diffuse liver diseases].
Loginov AS; Blok IuE; Shepeleva SD; Tkachev VD
Ter Arkh; 1981; 53(11):50-9. PubMed ID: 7339906
[No Abstract] [Full Text] [Related]
7. [Long-term treatment of chronic hepatitis and liver cirrhosis].
Pusch JH; Ullmann W
Med Klin; 1975 Apr; 70(15):674-81. PubMed ID: 806771
[No Abstract] [Full Text] [Related]
8. [Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis].
Bakulenko EF
Vrach Delo; 1976 Apr; (4):108-10. PubMed ID: 1007172
[No Abstract] [Full Text] [Related]
9. [Study of the in vitro effect of hydrocortisone and D-penicillamine on the liver of patients with chronic hepatitis and liver cirrhosis].
Gichev IuP; Bakulina LF
Ter Arkh; 1980; 52(7):113-7. PubMed ID: 7404399
[No Abstract] [Full Text] [Related]
10. [Immunosuppressive therapy of inflammatory liver diseases].
Meyer zum Büschenfelde ; Perings E; Crettzfeldt W
Ther Umsch; 1971 Sep; 28(9):586-95. PubMed ID: 5122521
[No Abstract] [Full Text] [Related]
11. [Therapy of liver cirrhosis].
Paumgartner G
Z Gastroenterol Verh; 1983 Apr; 18():63-9. PubMed ID: 6192610
[No Abstract] [Full Text] [Related]
12. [Clinical aspects and immunology of chronic active autoimmune hepatitis and primary biliary cirrhosis].
Berg PA
Immun Infekt; 1982 Jan; 10(1):3-14. PubMed ID: 6461591
[No Abstract] [Full Text] [Related]
13. [Treatment of patients with chronic hepatitis and cirrhosis of the liver].
Kurdybaĭlo FV; Larina IG; Kulikova AN
Vrach Delo; 1972 Jun; 6():19-23. PubMed ID: 5043595
[No Abstract] [Full Text] [Related]
14. [Results of controlled therapeutic trials of D-penicillamine in chronic hepatitis].
Bielawski W; Kaszewska-Jablońska I; Górski M
Pol Arch Med Wewn; 1976; 55(3):211-21. PubMed ID: 1257111
[No Abstract] [Full Text] [Related]
15. Treatment of active chronic hepatitis and active cirrhosis with penicillamine.
Schnack H
Postgrad Med J; 1974 Aug; 50 Suppl 2():44. PubMed ID: 4467178
[No Abstract] [Full Text] [Related]
16. [Chronic hepatitis. Current problems].
Thomas M; Hecht Y
Nouv Presse Med; 1972 Feb; 1(9):573-4. PubMed ID: 5022902
[No Abstract] [Full Text] [Related]
17. [Effect of complex therapy on the electrolyte metabolism in patients with chronic hepatitis and liver cirrhosis].
Rudyk BI
Vrach Delo; 1973 Sep; 9():89-93. PubMed ID: 4768488
[No Abstract] [Full Text] [Related]
18. [The treatment of chronic aggressive hepatitis with D-penicillamine].
Lange J; Schumacher K; Witscher HP
Dtsch Med Wochenschr; 1971 Jan; 96(4):139-45 passim. PubMed ID: 5539526
[No Abstract] [Full Text] [Related]
19. [Long-term therapy of liver diseases].
Markoff N
Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921
[No Abstract] [Full Text] [Related]
20. Controlled trial of D-penicillamine with low dosis in the treatment of chronic liver diseases.
Nakano H; Ohnishi S; Sugiyama T; Miyamura M; Imura H; Yamamoto Y; Ito K
Gastroenterol Jpn; 1980; 15(4):374-8. PubMed ID: 6997130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
